V Martinelli1, A Cappa2, M Zugnoni3,4, S Cappello3,4, S Masi3,4, C Klersy3,5, E Pellegrino3, C Muggia3,6, C Cavallotto2, P Politi2, F Bruno3, N Mineo3, A Peri3, F Lobascio4, M Chiappedi7, A Dakanalis8, A Pietrabissa3, R Caccialanza4. 1. Bariatric Surgery Team, Unit of General Surgery 2, IRCCS Policlinico San Matteo Foundation, Pavia, Italy. valentina.martinelli@unipv.it. 2. Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy. 3. Bariatric Surgery Team, Unit of General Surgery 2, IRCCS Policlinico San Matteo Foundation, Pavia, Italy. 4. Clinical Nutrition and Dietetics Unit, IRCCS Policlinico San Matteo Foundation, Pavia, Italy. 5. Service of Clinical Epidemiology & Biometry, IRCCS Policlinico San Matteo Foundation, Pavia, Italy. 6. Department of Internal Medicine, Clinica Medica 1, IRCCS Policlinico San Matteo Foundation, Pavia, Italy. 7. Child Neurology and Psychiatry, IRCCS Mondino Foundation, Pavia, Italy. 8. Department of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.
Abstract
PURPOSE: This cross-sectional study aimed at comparing the quality of life (Qol), the prevalence of psychiatric diagnosis and pharmacological treatment in 104 candidates to bariatric surgery according to the degree of obesity (class 2 vs. class ≥ 3 obesity). METHODS: All surgical candidates underwent a detailed psychiatric interview based on DSM-5 criteria, including sociodemographic, clinical, psychological and psychiatric data. Participants completed the Binge Eating Scale (BES) and the 12-Item Short Form Health Survey (SF-12). RESULTS: Overall, bariatric candidates reported a significant impairment in the physical (PCS 38.8 [95% CI 36.2-41.5]) and mental (MCS 42.2 [95% CI 40.4-43.9]) components of Qol compared to population norms (p < 0.001 for both). Subjects with class 2 obesity scored significantly lower in the MCS compared to those with class 3 (38.7 (8.1) vs. 43.6 (8.4), p = 0.008). No other statistically significant differences were found between the two groups in terms of sociodemographic and clinical variables. CONCLUSION: These data support the usefulness of Qol assessment in bariatric candidates as a sensible screening parameter, especially in patients with lower BMI, in whom MCS could identify the need for early psychosocial intervention. LEVEL OF EVIDENCE: Level III, case-control analytic study.
PURPOSE: This cross-sectional study aimed at comparing the quality of life (Qol), the prevalence of psychiatric diagnosis and pharmacological treatment in 104 candidates to bariatric surgery according to the degree of obesity (class 2 vs. class ≥ 3 obesity). METHODS: All surgical candidates underwent a detailed psychiatric interview based on DSM-5 criteria, including sociodemographic, clinical, psychological and psychiatric data. Participants completed the Binge Eating Scale (BES) and the 12-Item Short Form Health Survey (SF-12). RESULTS: Overall, bariatric candidates reported a significant impairment in the physical (PCS 38.8 [95% CI 36.2-41.5]) and mental (MCS 42.2 [95% CI 40.4-43.9]) components of Qol compared to population norms (p < 0.001 for both). Subjects with class 2 obesity scored significantly lower in the MCS compared to those with class 3 (38.7 (8.1) vs. 43.6 (8.4), p = 0.008). No other statistically significant differences were found between the two groups in terms of sociodemographic and clinical variables. CONCLUSION: These data support the usefulness of Qol assessment in bariatric candidates as a sensible screening parameter, especially in patients with lower BMI, in whom MCS could identify the need for early psychosocial intervention. LEVEL OF EVIDENCE: Level III, case-control analytic study.
Entities:
Keywords:
Bariatric surgery; Binge eating disorder; Body mass index; Obesity class; Quality of life
Authors: James E Mitchell; Faith Selzer; Melissa A Kalarchian; Michael J Devlin; Gladys W Strain; Katherine A Elder; Marsha D Marcus; Steve Wonderlich; Nicholas J Christian; Susan Z Yanovski Journal: Surg Obes Relat Dis Date: 2012-07-14 Impact factor: 4.734
Authors: Melissa A Kalarchian; Marsha D Marcus; Michele D Levine; Anita P Courcoulas; Paul A Pilkonis; Rebecca M Ringham; Julia N Soulakova; Lisa A Weissfeld; Dana L Rofey Journal: Am J Psychiatry Date: 2007-02 Impact factor: 18.112
Authors: Robin M Masheb; Marney A White; Claudia M Toth; Carolyn H Burke-Martindale; Bruce Rothschild; Carlos M Grilo Journal: Compr Psychiatry Date: 2007-03-29 Impact factor: 3.735